Novartis India Jun '11 sales at Rs 197.78 crore

Published on Tue, Jul 26, 2011 at 16:37 |  Source : Moneycontrol.com

2455 Investors following Novartis India. Share this News with them.
0
0
Share on Tumblr
Novartis India Jun '11 sales at Rs 197.78 crore

ALSO READ

Novartis India has reported a sales turnover of Rs 197.78 crore and a net profit of Rs 37.57 crore for the quarter ended Jun '11.
For the quarter ended Jun 2010 the sales turnover was Rs 177.17 crore and net profit was Rs 31.53 crore.
Quarterly Results of Novartis India-------- in Rs. Cr. --------
Jun '10Mar '11Jun '11
Sales Turnover177.17180.84197.78
Other Income12.0817.4416.74
Total Income189.25198.28214.52
Total Expenses141.23145.87158.08
Operating Profit35.9434.9739.70
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit48.0252.4156.44
Interest0.060.100.08
PBDT47.9652.3156.36
Depreciation0.470.700.43
Depreciation On Revaluation Of Assets------
PBT47.4951.6155.93
Tax15.9617.5318.36
Net Profit31.5334.0837.57
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share9.8710.6611.76
Book Value------
Equity15.9815.9815.98
Reserves------
Face Value5.005.005.00
Source : Religare Technova

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!